Home Search

viaskin peanut - search results

If you're not happy with the results, please do another search
Viaskin Patch

Viaskin Patch Delivers Long-Lasting Peanut Desensitization After Phase IIb Trial

Dave Bloom - 0
The study was designed to assess the long-term efficacy and safety of the treatment in subjects that had graduated from their earlier VIPES trial.
Viaskin Peanut

Peanut Patch Treatment Continues to Help Toddlers Safely Build Tolerance Over Three Years

News Wire ~ 3rd Party Press Release - 0
After three years of treatment, more than 70% could tolerate about three to four peanut kernels.
Viaskin Peanut

Children’s Response to Peanut Patch Therapy Increased Over 60 Months

Dave Bloom - 0
VP250 may lead to an accumulation of clinical benefit with high treatment compliance, making this a valuable option for children with allergies.
Viaskin Patch

Viaskin Milk Results Shows Potential for Treatment of Milk Allergy in Children

Dave Bloom - 0
95.5% of the participants completed treatment, with most adverse effects being mild or moderate reactions at the application site.
Viaskin-Patch

FDA Removes Hold Allowing DBV’s Pivotal Phase 3 Peanut Patch Trial to Commence

Dave Bloom - 0
The phase 3 trial of the modified Viaskin Peanut patch has been cleared for commencement.
Viaskin Patch

Skin Patch Immunotherapy Determined Safe and Effective in Toddlers With Peanut Allergy

Dave Bloom - 0
According to research presented at this year's #ACAAI22 meeting.
DBV Patch Closeup

DBV, Developers of Patch Therapies for Allergies to Peanuts, Milk and Eggs, to Lay...

Dave Bloom - 0
The company announced they would be laying off 200 employees in Q1.
FARE Reponse to ICER Report

Fare Responds to Final ICER Review of Breakthrough Peanut Allergy Therapies

News Wire ~ 3rd Party Press Release - 0
FARE expresses its deep concerns with the final evidence report on two breakthrough peanut allergy therapies issued Wednesday by ICER.
AAFA Reponse to ICER Report

Asthma and Allergy Foundation of America Responds to Premature ICER Review of New Peanut...

Dave Bloom - 0
The AAFA addresses concerns regarding the Final Evidence Report released by the ICER.
ICER Final Report

ICER’s Final Report on Peanut Allergy Treatments: Clinical Evidence Does Not Yet Demonstrate That...

News Wire ~ 3rd Party Press Release - 0
The report evaluates Viaskin® Peanut and AR101, as well as non-commercialized oral immunotherapy (OIT).
1...345...7Page 4 of 7

Your School On Our Map